Package 16110-833-10

Brand: tazorac

Generic: tazarotene
NDC Package

Package Facts

Identity

Package NDC 16110-833-10
Digits Only 1611083310
Product NDC 16110-833
Description

1 TUBE in 1 CARTON (16110-833-10) / 100 g in 1 TUBE

Marketing

Marketing Status
Marketed Since 2020-02-21
Brand tazorac
Generic tazarotene
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["CUTANEOUS"], "spl_id": "7e6df473-8f69-4d67-bd06-a24f35ab0a62", "openfda": {"nui": ["N0000175607", "M0018962"], "upc": ["0316110042107", "0316110042305", "0316110833309", "0316110833101"], "unii": ["81BDR9Y8PS"], "rxcui": ["212437", "212438", "313199", "313201"], "spl_set_id": ["4e4e4b81-420e-4492-8a74-80b692a80057"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (16110-833-10)  / 100 g in 1 TUBE", "package_ndc": "16110-833-10", "marketing_start_date": "20200221"}, {"sample": false, "description": "1 TUBE in 1 CARTON (16110-833-30)  / 30 g in 1 TUBE", "package_ndc": "16110-833-30", "marketing_start_date": "20200221"}], "brand_name": "Tazorac", "product_id": "16110-833_7e6df473-8f69-4d67-bd06-a24f35ab0a62", "dosage_form": "GEL", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "16110-833", "generic_name": "tazarotene", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tazorac", "active_ingredients": [{"name": "TAZAROTENE", "strength": ".5 mg/g"}], "application_number": "NDA020600", "marketing_category": "NDA", "marketing_start_date": "20200221", "listing_expiration_date": "20261231"}